Open‐label, clinical trial extension: Two‐year safety and efficacy results of seladelpar in patients with primary biliary cholangitis

Mayo, Marlyn J., Vierling, John M., Bowlus, Christopher L. · Alimentary Pharmacology & Therapeutics · 2024